EBASTEL

DEAD

Serial Number

75521329

Owner

FORDONAL, S.L.

Attorney

Lawrence E. Apolzon

Filing Date

Jul 20, 1998

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EBASTEL Trademark

Serial Number: 75521329 • Registration: 2374306

EBASTEL is a trademark filed by FORDONAL, S.L. on July 20, 1998. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

FORDONAL, S.L.

Lerida 9
28020 Madrid , ES

Entity Type: 03

ALMIRALL-PRODESFARMA S.A. (30 trademarks)

NUMERO 151
BARCELONA , ES

Entity Type: 03

Legal Representation

Attorney of Record

Lawrence E. Apolzon

4,992 trademarks filed View all →

Trademark Details

Filing Date

July 20, 1998

Registration Date

August 8, 2000

Published for Opposition

January 11, 2000

Cancellation Date

March 11, 2011

Goods & Services

antihistamine pharmaceutical indicated for the treatment of allergies, dizziness and respiratory disorders, in general

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Mar 11, 2011 CAEX

CASE FILE IN TICRS

Mar 17, 2006 CFIT

CORRECTION UNDER SECTION 7 - PROCESSED

Feb 21, 2002 COC.

RESPONSE RECEIVED TO POST REG. ACTION

Jan 31, 2001 RRPR

POST REGISTRATION ACTION MAILED - SEC. 7

Dec 4, 2000 PRAM

SEC 7 REQUEST FILED

Sep 14, 2000 AMD7

REGISTERED-PRINCIPAL REGISTER

Aug 8, 2000 R.PR

EXTENSION OF TIME TO OPPOSE RECEIVED

Feb 8, 2000 ETOF

PUBLISHED FOR OPPOSITION

Jan 11, 2000 PUBO

NOTICE OF PUBLICATION

Dec 10, 1999 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 7, 1999 CNSA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 27, 1999 CRFA

LETTER OF SUSPENSION MAILED

May 11, 1999 CNSL

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 16, 1999 CRFA

NON-FINAL ACTION MAILED

Mar 25, 1999 CNRT

ASSIGNED TO EXAMINER

Mar 18, 1999 DOCK

Related Trademarks

More from this Owner

ACCLA!M ANTICHOLINERGIC LAS 34273 COPD CLINICAL TRIAL ASSESSING EFFICACY AND SAFETY IN MODERATE TO SEVERE COPD PATIENTS

ACCLAIM / COPD

More in Same Class

SYSCO